Metraipolis › archive › dc_439a5fbc75ff

Mirabegron Versus Tamsulosin in Reducing Double-J Stent-Related Symptoms: A Prospective Comparative Study — Europe PMC PMID:41080378

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41080378
DOI: 10.7759/cureus.91925
License (as archived): solo-consultazione
Archived: 2026-11-10T01:22:15.127Z
SHA-256 of the archived text: 3bc7f00ddb2077e9f77bbf92374b27b69a92f180d63d442648501af917eef57e
Stable URL of this page: https://metraipolis.com/documento/dc_439a5fbc75ff

How to cite

Mirabegron Versus Tamsulosin in Reducing Double-J Stent-Related Symptoms: A Prospective Comparative Study — Europe PMC PMID:41080378 — Europe PMC (en), https://europepmc.org/article/MED/41080378 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_439a5fbc75ff (Metraipolis archive dc_439a5fbc75ff, sha256 3bc7f00ddb2077e9f77bbf92374b27b69a92f180d63d442648501af917eef57e)

BibTeX

@misc{dc439a5fbc75ff,
  title = {Mirabegron Versus Tamsulosin in Reducing Double-J Stent-Related Symptoms: A Prospective Comparative Study — Europe PMC PMID:41080378},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41080378},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_439a5fbc75ff; sha256 3bc7f00ddb2077e9f77bbf92374b27b69a92f180d63d442648501af917eef57e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41080378. Agents can read the archived copy with the MCP tool read_document.